Τίτλος:
Genetic heterogeneity of platelet glycoproteins Ia and IIIa is associated with in vitro fertilisation implantation failure
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Thrombophilic genetic factors have been shown to play an important role in implantation outcome after in vitro fertilisation (IVF). In this pilot study we investigated the frequencies of glycoprotein Ia (GpIa)-C807T and GpIIIa-PlA1/PlA2 polymorphisms in 60 nulligravidae women with a history of unexplained IVF implantation failures and compared them with 60 healthy fertile women. We found statistically significant associations between the GpIa-C807T and GpIIIa-PlA1/PlA2 polymorphisms and IVF implantation failure (odds ratio [OR] = 3.45, 95% confidence interval [CI]: 1.63-7.30, p = 0.001; and OR = 2.86, 95% CI: 1.27-6.45, p = 0.010, respectively) with the risk being higher for combined carriers of GpIa-807T and GpIIIa-PlA2 alleles (OR = 10.13, 95% CI: 2.85-35.99, p < 0.001), suggesting a synergistic effect of the two polymorphisms. The above associations were strongest for the youngest age group. Our results indicate that GpIa-807T and GpIIIa-PlA2 may be susceptibility alleles for IVF implantation failure. © 2015 © 2015 Taylor & Francis Group, LLC.
Συγγραφείς:
Vlachadis, N.
Tsamadias, V.
Kouskouni, E.
Vitoratos, N.
Hatziveis, K.
Economou, E.
Περιοδικό:
JOURNAL OF OBSTETRICS AND GYNAECOLOGY
Εκδότης:
Taylor and Francis Ltd.
Λέξεις-κλειδιά:
alpha2 integrin; glycoprotein IIIa; alpha2 integrin; beta3 integrin, adult; allele; Article; controlled study; DNA polymorphism; female; fertilization in vitro; gene frequency; genetic association; genetic heterogeneity; genetic risk; genetic susceptibility; groups by age; heterozygote; human; major clinical study; nidation; nulligravida; pilot study; priority journal; treatment failure; aged; case control study; genetics; in vitro fertilization; middle aged; single nucleotide polymorphism; treatment failure, Adult; Aged; Alleles; Case-Control Studies; Embryo Implantation; Female; Fertilization in Vitro; Humans; Integrin alpha2; Integrin beta3; Middle Aged; Pilot Projects; Polymorphism, Single Nucleotide; Treatment Failure
DOI:
10.3109/01443615.2015.1004528
